Dupilumab in the management of moderate-to-severe asthma: the data so far

Dupilumab in the management of moderate-to-severe asthma: the data so far

Pilar Barranco,1 Elsa Phillips-Angles,2 Javier Dominguez-Ortega,1 Santiago Quirce1 1Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; 2Department of Allergy, Hospital La Paz Institute for He...

Full description

Bibliographic Details
Main Authors: Barranco P, Phillips-Angles E, Dominguez-Ortega J, Quirce S
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Therapeutics and Clinical Risk Management
Subjects:
dupilumab
asthma
interleukin-4
interleukin-13
monoclonal antibodies
treatment
Online Access:https://www.dovepress.com/dupilumab-in-the-management-of-moderate-to-severe-asthma-the-data-so-f-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/dupilumab-in-the-management-of-moderate-to-severe-asthma-the-data-so-f-peer-reviewed-article-TCRM

Similar Items